TriSalus Life Sciences
TLSI
TLSI
30 hedge funds and large institutions have $12.4M invested in TriSalus Life Sciences in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
30
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$893K | |
| 2 | +$603K | |
| 3 | +$301K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$251K |
| 5 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$140K |
Top Sellers
| 1 | -$175K | |
| 2 | -$105K | |
| 3 | -$92K | |
| 4 |
Millennium Management
New York
|
-$86.9K |
| 5 |
HF
HRT Financial
New York
|
-$71K |